Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 213

Similar articles for PubMed (Select 23324995)

1.

Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Michishita I.

J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):320-6. doi: 10.1177/1074248412473202. Epub 2013 Jan 15.

PMID:
23324995
2.

Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Am J Cardiol. 2013 Jun 1;111(11):1570-5. doi: 10.1016/j.amjcard.2013.01.327. Epub 2013 Mar 13.

PMID:
23497779
3.

Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Am J Cardiol. 2013 Jan 1;111(1):6-11. doi: 10.1016/j.amjcard.2012.08.038. Epub 2012 Oct 2.

PMID:
23040588
4.

Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease.

Kurisu S, Ishibashi K, Kato Y, Mitsuba N, Dohi Y, Nishioka K, Kihara Y.

Heart Vessels. 2013 Jan;28(1):34-8. doi: 10.1007/s00380-011-0213-6. Epub 2011 Dec 21.

PMID:
22187148
5.

Correlation of omega-3 levels in serum phospholipid from 2053 human blood samples with key fatty acid ratios.

Holub BJ, Wlodek M, Rowe W, Piekarski J.

Nutr J. 2009 Dec 24;8:58. doi: 10.1186/1475-2891-8-58.

6.

Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.

Shoji T, Kakiya R, Hayashi T, Tsujimoto Y, Sonoda M, Shima H, Mori K, Fukumoto S, Tahara H, Shioi A, Tabata T, Emoto M, Nishizawa Y, Inaba M.

Am J Kidney Dis. 2013 Sep;62(3):568-76. doi: 10.1053/j.ajkd.2013.02.362. Epub 2013 Apr 17.

PMID:
23602192
7.

Comparison of effects of pitavastatin versus pravastatin on serum proprotein convertase subtilisin/kexin type 9 levels in statin-naive patients with coronary artery disease.

Nozue T, Hattori H, Ishihara M, Iwasaki T, Hirano T, Kawashiri MA, Yamagishi M, Michishita I.

Am J Cardiol. 2013 May 15;111(10):1415-9. doi: 10.1016/j.amjcard.2013.01.289. Epub 2013 Feb 20.

PMID:
23433768
8.

Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men.

Safarinejad MR, Hosseini SY, Dadkhah F, Asgari MA.

Clin Nutr. 2010 Feb;29(1):100-5. doi: 10.1016/j.clnu.2009.07.008. Epub 2009 Aug 8.

PMID:
19666200
9.

Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke.

Suda S, Katsumata T, Okubo S, Kanamaru T, Suzuki K, Watanabe Y, Katsura K, Katayama Y.

Cerebrovasc Dis. 2013;36(5-6):388-93. doi: 10.1159/000355683. Epub 2013 Nov 15.

PMID:
24248098
10.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
11.

Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.

Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE.

Pharmacotherapy. 2007 May;27(5):633-8.

PMID:
17461697
12.

Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.

de Oliveira Otto MC, Wu JH, Baylin A, Vaidya D, Rich SS, Tsai MY, Jacobs DR Jr, Mozaffarian D.

J Am Heart Assoc. 2013 Dec 18;2(6):e000506. doi: 10.1161/JAHA.113.000506.

13.

Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention.

Domei T, Yokoi H, Kuramitsu S, Soga Y, Arita T, Ando K, Shirai S, Kondo K, Sakai K, Goya M, Iwabuchi M, Ueeda M, Nobuyoshi M.

Circ J. 2012;76(2):423-9. Epub 2011 Dec 8.

14.

Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy.

Urabe Y, Yamamoto H, Kitagawa T, Utsunomiya H, Tsushima H, Tatsugami F, Awai K, Kihara Y.

Circ J. 2013;77(10):2578-85. Epub 2013 Jul 18.

15.

Association of plasma ω-3 to ω-6 polyunsaturated fatty acid ratio with complexity of coronary artery lesion.

Hayakawa S, Yoshikawa D, Ishii H, Tanaka M, Kumagai S, Matsumoto M, Hayashi M, Sugiura T, Hayashi K, Ando H, Amano T, Murohara T.

Intern Med. 2012;51(9):1009-14. Epub 2012 Apr 29.

16.

Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio.

Kashiyama T, Ueda Y, Nemoto T, Wada M, Masumura Y, Matsuo K, Nishio M, Hirata A, Asai M, Kashiwase K, Kodama K.

Circ J. 2011;75(10):2432-8. Epub 2011 Jul 20.

17.

Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients.

Harris JI, Hibbeln JR, Mackey RH, Muldoon MF.

Prostaglandins Leukot Essent Fatty Acids. 2004 Oct;71(4):263-9.

PMID:
15310527
18.

Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I.

Cardiovasc Diabetol. 2014 Jan 13;13:13. doi: 10.1186/1475-2840-13-13.

19.

Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome.

Nishizaki Y, Shimada K, Tani S, Ogawa T, Ando J, Takahashi M, Yamamoto M, Shinozaki T, Miyauchi K, Nagao K, Hirayama A, Yoshimura M, Komuro I, Nagai R, Daida H.

Am J Cardiol. 2014 Feb 1;113(3):441-5. doi: 10.1016/j.amjcard.2013.10.011. Epub 2013 Nov 7.

PMID:
24326273
20.

A meta-analytic review of polyunsaturated fatty acid compositions in dementia.

Lin PY, Chiu CC, Huang SY, Su KP.

J Clin Psychiatry. 2012 Sep;73(9):1245-54. doi: 10.4088/JCP.11r07546. Epub 2012 Aug 7. Review.

PMID:
22938939
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk